Compare CDMOs with ICH stability testing capabilities. Filter by chamber capacity, ICH condition support, and regulatory filing experience.
472 companies listed
Canada
Delpharm is one of the world's top five CDMOs, specializing in the development and manufacture of medicines across solid, sterile, semi-solid, and liquid dosage forms with particular expertise in nasal sprays and injectables. The company operates 18 manufacturing sites and 3 development centers across Europe and North America, with 6,500 employees and over 1.1 billion EUR in turnover. Delpharm produces over 650 million units annually and recently received a $60 million Canadian government investment to modernize its Boucherville injectable facility.
United States
DifGen Pharmaceuticals is a US-based CDMO specializing in complex generics and advanced drug delivery systems, providing end-to-end solutions from product development through commercial manufacturing. Through its 2023 acquisition of Aveva Drug Delivery Systems Inc., DifGen gained a 455,000 sq. ft. US manufacturing footprint producing over 300 million transdermal patches annually, including controlled substances like buprenorphine transdermal systems.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.